Technology

Alpine Immune Sciences

$12.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.41 (-3.12%) Today
$0.00 (0.00%) As of 12:18 PM UTC after-hours

Why Robinhood?

You can buy or sell ALPN and other stocks, options, and ETFs commission-free!

About ALPN

Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company. The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA. The listed name for ALPN is Alpine Immune Sciences, Inc. Common Stock.

CEO
Mitchell H. Gold
Employees
53
Headquarters
Seattle, Washington
Founded
2015
Market Cap
306.46M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
128.49K
High Today
$13.46
Low Today
$12.35
Open Price
$13.20
Volume
118.71K
52 Week High
$16.37
52 Week Low
$2.05

Collections

ALPN Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, After Hours

You May Also Like

RYJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure